Advancements in CRISPR/Cas systems for disease treatment
The clustered regularly interspaced short palindromic repeats (CRISPR)-Cas (CRISPR-associated proteins) is an adaptive immune system present in most bacteria and archaea, protecting them from infection by exogenous genetic elements. Due to its simplicity, cost-effectiveness, and precise gene editing...
Saved in:
| Main Authors: | Yangsong Xu, Hao Le, Qinjie Wu, Ning Wang, Changyang Gong |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-06-01
|
| Series: | Acta Pharmaceutica Sinica B |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2211383525003132 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The CRISPR/Cas system: Gene Editing by bacterial defense
by: Amira H. El-Ashry
Published: (2023-09-01) -
Nanotechnology-Based Delivery of CRISPR/Cas9 for Cancer Treatment: A Comprehensive Review
by: Mohd Ahmar Rauf, et al.
Published: (2025-07-01) -
Harnessing bacterial immunity: CRISPR-Cas system as a versatile tool in combating pathogens and revolutionizing medicine
by: Mushtak T. S. Al-Ouqaili, et al.
Published: (2025-05-01) -
Advances in CRISPR/Cas9-Based Gene Editing in Filamentous Fungi
by: Bin Ma, et al.
Published: (2025-05-01) -
CRISPR/Cas9: Role of genome editing in cancer immunotherapy
by: S. Vimal, et al.
Published: (2024-06-01)